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Osteopontin, a secreted glycoprotein has been implicated
in several renal pathological conditions such as those due
to ureteral obstruction, ischemia, and cyclosporine toxicity.
We studied its possible role in angiotensin II–mediated
renal injury by infusing wild-type and osteopontin knockout
mice with angiotensin II and found that it raised blood
pressure and increased urinary albumin/creatinine ratios
in both strains of mice. However, while wild-type mice
responded to the infusion by macrophage infiltration and
increased expression of a-smooth muscle actin, fibronectin,
and transforming growth factor-b; the osteopontin knockout
mice developed none of these. Further, the knockout mice
had increased expression of monocyte chemoattractant
protein-1; NADPH oxidase subunits such as NOX2,
gp47phox, and NOX4; and plasminogen activator inhibitor-1
compared to the wild type animals. Proximal tubule epithelial
cells in culture treated with recombinant osteopontin and
angiotensin II had increased a-smooth muscle actin and
transforming growth factor-b expression. The effect of
angiotensin II was blocked by an antibody to osteopontin.
In addition, osteopontin attenuated angiotensin II-induced
plasminogen activator inhibitor-1 expression. These studies
show that osteopontin is a promoter and an inhibitor of
inflammation, oxidative stress, and fibrosis that is capable
of modulating angiotensin II–induced renal damage.
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Angiotensin II (AngII) is a main player in the pathogenesis of
hypertensive nephropathy, which is a leading cause of chronic
kidney disease and its progression to end stage renal disease.1
Some of the deleterious effects of AngII on the kidney include
recruitment of inflammatory cells to the glomerulus,2,3
induction of collagen type IV synthesis in the glomerular
basement membrane,4 enhancement of an inflammatory
response in the proximal tubular cells,5 and fibrosis in the
renal tubular interstitium. One of the mediators expressed in
AngII-injured tissue is osteopontin (OPN).6,7 OPN is a
matrix glycoprotein containing an arginine glycine aspartate
(RGD) motif that binds to the integrin family of receptors
and a soluble cytokine. It is highly expressed in damaged
tissues and plays a role in wound healing possibly by
regulating inflammation and fibrosis.8,9 The link between
OPN and AngII in the kidney is evident from studies in
which blockade of one or more of the renin–angiotensin–
aldosterone system components downregulated the OPN
expression.10,11 The role of OPN in renal damage has been
investigated in various animal models such as post-ischemic
nephropathy,12 obstructive nephropathy,13 and chronic
allograft damage.14 We and others have examined the effect
of AngII on the cardiovascular structure and have shown that
the lack of OPN attenuates both cardiac fibrosis15,16 and
aortic aneurysm formation.17 This implied that OPN might
play a role in AngII-mediated renal injury.
OPN may participate in the host response to tissue
injury by regulating inflammation, epithelial–mesenchymal
transition, and fibrosis.18,19 The balance between the pro-
and anti-inflammatory actions of OPN results in modulation
of processes involved in tissue damage and fibrosis.18 Follow-
ing tissue damage, OPN facilitates macrophage and T-cell
recruitment20,21 and simultaneously attenuates secondary
injury by decreasing production of peroxynitrite, a highly
cytotoxic nitrogen species.22,23 By the induction of inducible
NO synthase and activation of NADPH oxidase, inflam-
mation increases production of peroxynitrite, which is the
byproduct of NO interaction with superoxide anion
(O2
).24,25 By inhibiting inducible NO synthase, OPN reduces
peroxynitrite production22,23 and thereby decreases oxidative/
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nitrosative stress in the inflammatory milieu. In proximal
tubular cells, inflammation and oxidative stress are followed
by mesenchymal transformation,26,27 in which epithelial cells
lose their epithelial phenotype and acquire mesenchymal
markers.28 This leads to deposition of collagen and other
matrix molecules, interstitial fibrosis, renal dysfunction,29,30
and potential progression towards end stage renal disease.
Several studies have been performed in different disease
models using OPN knockout mice to elucidate the role of
OPN in fibrogenesis. For instance, lack of OPN has been
shown to attenuate mesenchymal transformation and renal
fibrotic markers in neonatal chronic unilateral ureteral
obstruction.13 In addition, OPN deficiency has been found
to impair wound healing19 and decrease collagen deposition
after myocardial infarction.31
In this study, we investigated the role of OPN in renal
inflammation, oxidative stress, and interstitial fibrosis using
OPN-null (OPN/) and wild-type (OPNþ /þ ) mice infused
with AngII for 4 weeks. The study revealed that OPN
modulates these processes to retard progression of renal
damage in AngII-induced hypertension.
RESULTS
Characteristics of study animals
The genotype of the study animals was confirmed by
quantitative RT-PCR. As expected, OPN expression was
essentially absent in AngII- and vehicle-infused OPN/ mice
(Figure 1). AngII-infusion resulted in a threefold increase in
OPN expression in the OPNþ /þ mice (Po0.05). The
baseline body weight, blood pressure, and urine volume did
not differ significantly between OPNþ /þ and OPN/ mice.
AngII-infusion  4 weeks led to a significant reduction
of body weight and a significant increase in blood pressure
and urine volume of equal magnitude in both OPNþ /þ and
OPN/ mice compared with their vehicle-infused counter-
parts (Po0.05). Kidney weight compared with tibia length
(to accommodate changes in body weight) was significantly
lower in AngII-infused OPNþ /þ and OPN/ than in
vehicle-infused mice (Table 1).
Effect of OPN on albuminuria
Baseline albumin-to-creatinine ratio (ACR) was minimal and
of similar magnitude among the study groups. AngII infusion
for 4 weeks markedly increased ACR in both OPNþ /þ
(Po0.05) and OPN/ (Po0.01). As in other models of
renal injury in OPN-null animals,12 we found no significant
difference in ACR among AngII-infused OPN/ compared
with AngII-infused OPNþ /þ mice (338.4 vs 218.2 mg/mg),
P¼ 0.10 determined by two-way ANOVA and non-
parametric Mann–Whitney U-test (Figure 2).
Pro- and anti-inflammatory effects of OPN in the kidney
AngII-infusion resulted in substantial interstitial macrophage
infiltration in both OPNþ /þ and OPN/ mice compared with
vehicle-infused OPNþ /þ and OPN/mice. However, the mag-
nitude of interstitial macrophage infiltration was significantly less
in AngII-infused OPN/ than in the AngII-infused OPNþ /þ
mice. These findings were evident on immunohistochemical
(IHC) staining for MOMA-2 (1.64±0.2/hfp compared with
2.8±0.2/high powered field, Figure 3a and b) and CD68
immunofluorescence (0.8±0.2/hfp compared with 2.18±0.25/
high powered field, Figure 4a and b) in AngII-infused OPN/
compared with AngII-infused OPNþ /þ mice, respectively,
(Po0.01). In addition, CD68 protein expression was 1.5-fold
lower in AngII-infused OPN/ compared with AngII-infused
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Figure 1 | Quantification of OPN and GAPDH mRNA expression
in kidney cortex RT-PCR. Animals were infused with AngII or
vehicle (PBS) for 4 weeks and RNA was isolated from kidney cortex
for quantitative RT-PCR. The graph shows relative expression
of OPN/GAPDH mRNA. OPN expression was negligible in
vehicle- and AngII-infused OPN/ mice. Values are expressed
as mean±s.e.m. #Po0.01, *Po0.05, n¼ 4.
Table 1 | Physiologic characteristics of mice
OPN+/+ OPN/
Vehicle (n = 12) Ang II–infused (n = 10) Vehicle (n = 12) Ang II–infused (n = 12)
Body weight, initial (g) 27.9±0.7 29.0±0.3 31.0±0.4 28.7±0.3
Body weight, final (g) 29.7±0.2 26.4±0.9a 29.0±0.0 24.2±0.3b
Systolic BP, initial (mm/Hg) 110.3±1.4 108.5±1.4 113.2±2.0 112.0±2.7
Systolic BP, final (mm/Hg) 109.1±2.4 163.4±4.1a 112.6±1.6 165.0±5.4b
Urine volume, initial (ml) 1.4±0.1 1.3±0.1 2.6±0.2 2.0±0.2
Urine volume, final (ml) 1.7±0.1 7.5±0.7a 1.3±0.2 5.0±0.8b
Kidney weight/tibia length  103 15.8±0.5 14.8±0.6a 13.5±0.4 11.8±0.3b
AngII, Angiotensin II; BP, blood pressure; OPN, osteopontin; OPN/, OPN knockout mice; OPN+/+, wild-type mice. Values are mean±s.e.m.
aPo0.05 compared with vehicle-infused OPN+/+. bPo0.05 compared with vehicle-infused OPN/.
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OPNþ /þ mice, Po0.05 (Figure 4c and d). No difference was
found between vehicle-infused OPNþ /þ and OPN/ animals.
These data indicate that OPN deficiency attenuated AngII-
induced macrophage recruitment to the kidney.
Renal cortical MCP-1 expression was significantly greater
in the vehicle-treated OPN/ mice than in their OPNþ /þ
counterparts. AngII infusion resulted in significant upregu-
lation of MCP-1 mRNA and protein expression in both
OPN/ and OPNþ /þ mice. However, MCP-1 mRNA and
protein expression was greater in AngII-infused OPN/
mice compared with AngII-infused OPNþ /þ mice. MCP-1
mRNA expression was 2-fold higher (Figure 5a) and MCP-1
protein expression was 3.5-fold higher (Figure 5b and c) in
AngII-infused OPN/ than in AngII-infused OPNþ /þ
mice, Po0.05. This observation is consistent with our
previous findings which demonstrated that MCP-1, a potent
macrophage recruiter,32 is more intensely expressed in
the aorta of AngII-infused double knockout ApoE–/–/OPN–/–
than single knockout ApoE–/–/OPNþ /þ mice.17 Our results
suggest that OPN significantly modulates renal AngII-
induced inflammation by attenuating MCP-1 expression.
Effect of OPN on NAD(P)H oxidase
To determine whether the absence of OPN significantly alters
AngII-induced upregulation of NADPH oxidase, we mea-
sured the expression of NOX4 (a kidney-specific NADPH
oxidase subtype33,34), NOX2, gp47phox and nitrotyrosine.
AngII increased NOX4 mRNA 420-fold and protein 3.5-
fold, Po0.01 (Figure 6a–c), NOX2 protein 1.7-fold, Po0.01
and gp47phox 1.8-fold, Po0.05 in OPN/ vs OPNþ /þ mice
(Figure 6d–g). There was also a significant increase in NOX4
(4-fold, Po0.01 and 7-fold, Po0.05) and NOX2 protein
(1.3-fold Po0.01 and 3.8-fold, Po0.01) in OPN/ and
OPNþ /þ compared with vehicle-infused OPN/ and
OPNþ /þ mice, respectively. gp47phox increased sixfold
between AngII-infused OPNþ /þ and vehicle-infused
OPNþ /þ mice; however, the 1.2-fold increase in gp47phox
between AngII-infused OPN/ and vehicle-infused OPN/
mice was not statistically different. Nitrotyrosine expression
increased 1.5-fold, Po0.05 in AngII-infused OPNþ /þ and
1.4-fold, Po0.05 in vehicle-infused OPN/ mice vs vehicle-
infused OPNþ /þ mice. The 1.2-fold increase in nitrotyrosine
expression in AngII-infused OPN/ was not significant
(Figure 6h and i). These data indicate that OPN deletion may
promote oxidative stress by upregulating NADPH oxidase
subtypes.
Effect of OPN on tubulointerstitial fibrosis
Both OPN and TGF-b1 have significant roles in wound
healing and fibrogenesis.35,36 Expression of TGF-b1, which is
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Figure 2 | Albumin-to-creatinine ratio (ACR) in OPNþ /þ vs
OPN/ animals. Following AngII or vehicle infusion for 4 weeks,
animals were placed in metabolic cages for collection of urine for
albumin and creatinine measurements and albumin-to-creatinine
determination. The initial ACR (mg/mg) was comparable in all the
study groups. Values are expressed as mean±s.d. #Po0.01,
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Figure 3 | Analysis of macrophage recruitment to the
tubulointerstitial area after 4 weeks of AngII infusion. (a)
Immunohistochemistry (IHC) for MOMA-2 staining. Macrophages
are stained brown. (b) Quantification of MOMA-2 IHC. Fifteen non-
overlapping digitized images per slide at  400 magnification
were analyzed and expressed as number of MOMA-2 positive-
stained cells per high-power field in the tubulointerstitial
cross-section area. Values are expressed as mean±s.e.m.
#Po0.01, n¼ 5.
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also an early fibrosis regulator37 was examined in vivo.
Quantitative RT-PCR demonstrated a 2-fold higher expres-
sion of TGF-b1 mRNA in AngII-infused OPN
þ /þ compared
with AngII-infused OPN/ animals (Figure 7a). TGF-b1
protein expression was similarly increased (Po0.01; Figure
7b and c). To further investigate the role of OPN on
TGF-b1 expression, we incubated confluent porcine proximal
tubular epithelial (PTE) cells with rmOPN or AngII.
Incubation with either rmOPN (10 nM) or AngII (107 M)
resulted in a 42-fold rise in TGF-b1 expression in a time-
dependent manner up to 24 h, Po0.05 (Figure 8a and b)
and a dose-dependent manner up to 2.3-fold with rmOPN
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Figure 4 | Immunofluorescence and quantification of kidney sections of CD68-positive staining and western blot analysis of renal
cortex from OPNþ /þ and OPN/ mice. (a) Arrows indicate regions of positive staining. (b) Fifteen non-overlapping digitized images per
slide at 400 magnification were analyzed. Data are expressed as the total number of CD68 positive–stained cells per high-power field in
the tubulointerstitial cross-section area. Values are expressed as mean±s.e.m. #Po0.01, *Po0.05, n¼ 5. (c) Representative western blot of
CD68 and b-actin protein. (d) Quantification of signals from western blots. Values are expressed as mean±s.e.m., *Po0.05, n¼ 10–12.
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Figure 5 | MCP-1 mRNA and protein expression in the kidney cortex. (a) Quantification of MCP-1 and GAPDH by quantitative RT-PCR.
(b) Representative western blot analysis of MCP–1 and b-actin protein. (c) Quantification of signals from western blots. Values are expressed
as mean±s.e.m. #Po0.01, *Po0.05, n¼ 8.
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Figure 6 | NOX4 mRNA and NOX4, NOX2, gp47phox, and nitrotyrosine protein expression in kidney cortex. (a) Quantification of NOX4
and GAPDH by RT-PCR. (b) Representative western blot analysis of NOX4 and b-actin protein. (c) Quantification of signals from western
blots. Values are expressed as mean±s.e.m. #Po0.01, *Po0.01, n¼ 4. (d) Representative western blot analysis of NOX2 and b-actin protein.
(e) Quantification of western blot signals for NOX2/b-actin protein ratio. (f) Representative western blot analysis of gp47phox and b-actin
protein. (g) Quantification of western blot signals for gp47phox/b-actin protein ratio. (h) Representative western blot analysis of nitrotyrosine
and b-actin protein. (i) Quantification of nitrotyrosine/b-actin protein ratio. Values are expressed as mean±s.e.m.; #Po0.01, *Po0.05,
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(1–10 nM) and AngII (109–104 M) at 24 h, Po0.05 (Figure
8c and d).
Effects of OPN on fibrotic markers in vivo and in vitro
We examined the role of OPN on expression of a-SMA, as a
marker of early interstitial fibrosis38 in AngII-mediated renal
injury by IHC (Figure 9a). Quantification showed that
compared with vehicle, AngII significantly increased a-SMA
expression in both OPNþ /þ and OPN/ mice (9.1±0.7 vs
1.3±0.14, and 4.9±0.5 vs 0.8±0.09, respectively, Po0.01).
The expression of a-SMA in AngII-infused OPNþ /þ was
significantly higher compared with AngII-infused OPN/
mice, Po0.01 (Figure 9b). Incubation of PTE cells with
either AngII (107 M) or rmOPN (10 nM) resulted in a 2–3
fold increase in a-SMA expression up to 24 h (Figure 9c
and d), and a dose-dependent increase up to 1.5-fold with
AngII (1012–104 M) and rmOPN (1–10 nM), Po0.05
(Figure 9e and f).
Effects of OPN on AngII-induced interstitial fibrosis
The expression of fibronectin and collagen IV was examined.
Fibronectin expression by IHC was significantly higher in
AngII-infused OPNþ /þ vs AngII-infused OPN/ (4.6±0.8
vs 1.2±0.3, Po0.01 (Figure 10a and b) and similarly increased
5-fold in AngII-infused OPNþ /þ vs AngII-infused OPN/
mice by western blot, Po0.05 (Figure 10c and d). On the
other hand, collagen IV IHC staining was increased in both
AngII-infused OPNþ /þ and OPN/ (6.3±0.8 and 6.1±0.6)
compared with vehicle-infused OPNþ /þ and OPN/ (1.6±
0.2 and 3.1±0.5) mice, Po0.01 (Figure 10e and f). This
suggests that OPN may more directly regulate fibronectin than
collagen IV expression in the early stages of fibrosis.
Effects of OPN on expression of AngII-induced fibrotic
markers in vivo and in vitro
Our group has described the upregulation of renal cortical
TGF-b1 by PAI-1.
39 In this study, we showed that the
expression of PAI-1 mRNA and protein was B3-fold higher
in AngII-infused OPNþ /þ compared with vehicle-infused
OPNþ /þ mice, Po0.05 and significantly increased in the
vehicle-infused OPN/ mice, but did not rise further with
AngII infusion (Figure 11a–c). To investigate the dual role of
OPN to modulate fibrosis, we examined the expression of
a-SMA, TGF-b1 and PAI-1 in vitro. PTE cells were untreated
or treated for 24 h with rmOPN (10 nM) or AngII (106 M)
or pre-treated  2 h with anti-OPN antibody. OPN antibody
did not alter a-SMA or TGF-b1, but increased PAI-1
expression 7-fold. OPN and AngII independently increased
the expression of a-SMA (B4-fold, Po0.01), TGF-b1
(B3–4-fold, Po0.01) and PAI-1 (B10-fold, Po0.01).
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However, the effect of AngII on a-SMA and TGF-b1 was
abolished with OPN antibody. There was a greater increase of
TGF-b1 compared with a-SMA or PAI-1 in the presence of
rmOPNþAngII (Figure 11d–i). This suggests that OPN also
enhances a-SMA, TGF-b1 through AngII and attenuates the
expression of PAI-1.
DISCUSSION
The present study demonstrated that by modulating
processes involved in inflammation, oxidative stress and
fibrosis, OPN may influence kidney damage in AngII-
induced hypertension. We found that AngII infusion
increases OPN expression in OPNþ /þ animals. OPN-
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deficient mice had attenuated tubulointerstitial macro-
phage infiltration, despite enhanced MCP-1 expression and
upregulation of NOX 4, NOX2, gp47phox, and nitrotyrosine
expression. In vivo analysis indicated that OPN functioned
similarly to AngII by increasing TGF-b1, a-SMA and
fibronectin expression, but unlike AngII, OPN reduced
PAI-1. Similarly, in vitro studies revealed that both AngII
and OPN increased TGF-b1 and a-SMA but decreased PAI-1
expression. These data suggest that OPN may exert both
pro- and anti-inflammatory effects to modulate the deleter-
ious effects of AngII on inflammation, oxidative stress, and
renal fibrosis.
The baseline and AngII-induced increase in systemic
blood pressure did not differ between OPNþ /þ and OPN/
mice. Albuminuria is a known feature of AngII-mediated
renal injury.12,40 Urinary albumin excretion was similar
in our AngII-infused OPN/ and OPNþ /þ mice, suggest-
ing that OPN may not directly contribute to the severity of
proteinuria and that in this model; proteinuria may be
secondary to AngII-induced hyperfiltration.41
AngII-induced interstitial macrophage infiltration was
significantly attenuated in our OPN/ mice. This phenom-
enon can be explained by the lack of OPN, which itself is a
macrophage chemoattractant.42,43 Paradoxically, AngII infu-
sion resulted in an exaggerated upregulation of MCP-1
(which is an important mediator of macrophage recruit-
ment44,45) in the OPN/ mice. This finding is consistent
with our earlier studies.17 Antus et al. have demonstrated that
infusion of AngII into animals facilitates macrophage
recruitment, perhaps either directly or through upregulation
of chemotactic molecules such as RANTES and possibly
OPN.46,47 The current results in the kidney are comparable to
our earlier findings in the aorta of ApoE–/–OPN–/– mice which
showed reduced expression of macrophage CD68 and
increased MCP-1 expression in AngII-infused ApoE–/–OPN–/–
mice compared with AngII-infused ApoE–/–OPNþ /þ mice.17
It thus appears that OPN may mitigate the AngII-mediated
inflammatory process by limiting the exuberant expression of
MCP-1. It is of note that certain conditions such as diabetic
nephropathy48,49 and autosomal-dominant polycystic kidney
disease50 are associated with concomitant upregulation of
MCP-1 and OPN. Conversely, in a rat model of anti-
glomerular basement membrane glomerulonephritis, expres-
sion of OPN and MCP-1 track inversely in different
compartments of the kidney. For instance in the glomerulus,
MCP-1 was highly expressed with lower OPN expression,
whereas in the tubulo-interstitial area, MCP-1 expression was
only slightly enhanced whereas OPN was maximally expres-
sed and paralleled tubulo-interstitial macrophage infiltra-
tion.51 Taken together, these results suggest that OPN
modulates inflammation through its pro- and anti-inflam-
matory actions to enhance macrophage recruitment and
simultaneously inhibit MCP-1 expression.
The most frequently described anti-inflammatory action
of OPN is inhibition of inducible NO synthase,18,52 which
together with activation/upregulation of NAD(P)H oxidase
can result in increased production of ROS and reactive
nitrogen species such as peroxynitrite. NOX2 is a homolog of
the gp91phox catalytic subunit of NADPH oxidase and a
major source of ROS formation in the kidney.53–55 Here, we
demonstrated that the AngII-induced upregulation of NOX2,
NOX4, and gp47phox was significantly amplified in the
absence of OPN. This was associated with a mild but
insignificant increase in nitrotyrosine abundance pointing to
slight increase in AngII-induced superoxide production in
OPN/ mice. In contrast to the AngII-induced renal injury,
Lai et al. reported that OPN deficiency downregulates
NADPH oxidase subunits NOX1, NOX2, p67phox, and
p47phox as well as ROS production in diabetes-induced
vascular disease.56 This suggests that the effect of OPN on
oxidative stress may be both tissue- and disease-specific.
The process of fibrosis is typically preceded by inflamma-
tion57 and oxidative stress,27,58 and the role of OPN in early
fibrosis has been extensively described. Van Timmeren et al.59
showed that the expression of OPN is limited to areas of
the kidney exhibiting enhanced kidney injury molecule-1
and a-SMA expression and macrophage accumulation. Persy
et al. found that OPN deficiency attenuates macrophage
infiltration and interstitial fibrosis following ischemic injury
in mice.12 Yoo et al. reported lower interstitial fibrosis
following neonatal unilateral ureteral obstruction in OPN/
mice compared with OPNþ /þ mice.13 Bedke et al. showed
that the beneficial effect of CCR1 (chemokine receptor)
antagonist in reducing fibrosis in the transplanted kidney is
associated with reductions of OPN, PAI-1, TGF-b1 and
a-SMA.14 In our study, AngII-induced upregulation of TGF-
b1 and a-SMA was significantly attenuated by OPN
deficiency pointing to the role of OPN in promoting TGF-
b1 and a-SMA expression. This was confirmed by our in vitro
studies which showed that as with AngII, rmOPN induces
TGF-b1 and a-SMA protein expression and the AngII-
induced increase in TGF-b1 and a-SMA was abolished by
pretreatment with OPN antibody. We also showed that the
rise in tissue fibronectin abundance after four weeks of AngII
infusion was attenuated by OPN deficiency. In contrast, there
was no attenuation of collagen IV expression.
PAI-1 mRNA and protein were significantly increased in
our OPN/ mice (compared with OPNþ /þ mice) suggest-
ing that OPN can constrain PAI-1 production. Ma et al.60
have shown that PAI-1 may upregulate OPN, thus the
increase in PAI-1 in our OPN/ mice may be, in part, due to
loss of the inhibitory action of OPN. On the other hand, the
increase in PAI-1 abundance in our OPN/ mice might be
due to the demonstrated increase in NOX4, as observed
earlier by Djordjevic et al.61 In vitro, PAI-1 expression was
increased by both rmOPN and AngII, but the AngII-induced
increase in PAI-1 was not altered by pretreatment with OPN
antibody. These data suggest that OPN may modulate fibrosis
by activating mediators such as TGF-b1 and a-SMA (possibly
through AngII) whereas concurrently inhibiting other
mediators such as PAI-1, to maintain controlled fibrosis
and perhaps promote tissue remodeling.
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In conclusion, OPN modulates inflammation in the
AngII-injured kidney by enhancing macrophage recruitment
to the tubular interstitium whereas simultaneously inhibiting
the expression of NOX2, gp47phox NOX4, and MCP-1.
Similarly, OPN modulates renal tissue fibrosis by enhancing
fibronectin, TGF-b1 and a-SMA expression and simulta-
neously inhibiting PAI-1 expression. These observations
illustrate two faces of OPN as promoter and inhibitor of
inflammation, oxidation and fibrosis in the course of AngII-
induced renal injury.
MATERIALS AND METHODS
Animals
Breeding pairs of osteopontin-knockout (OPN/) mice on a Black
Swiss background were the generous gift of R Johnson and
C Giachelli with the permission of L Liaw.19 Wild-type OPN mice
(OPNþ /þ ) were controls. Eight-week old mice (27.9–31 g) were
anesthetized with isoflurane and osmotic mini-pumps (Alza Corp.,
Palo Alto, CA, USA) with AngII (2.5 mg/kg per min) in phosphate-
buffered saline (PBS), or PBS (vehicle) were implanted subcuta-
neously. Animals were habituated to BP measurements by indirect
tail-cuff plethysmography (Visitech Systems, Apex, NC, USA) prior
to initiation of the study until a plateau was reached (X10 times per
day  4 days) then weekly  4 weeks for daily mean values. Animals
were placed in metabolic cages for 24-h urine collection at the
beginning and end of the study. Urinary albumin and creatinine
were measured by Albuwell M Assay and Creatinine Companion
(Exocel, Philadelphia, PA, USA) for ACR. After killing by
pentobarbital overdose, the animals for body weight/tibia length
were weighed; tibia length was measured, which remains fairly
constant with body weight changes. The kidneys were removed,
weighed and either snap-frozen in liquid nitrogen and maintained at
801C or prepared for histologic analysis.
Immunohistochemistry
Fibronectin, collagen IV and a-SMA expressed by myofibroblasts
and macrophage MOMA-2 were detected by IHC by the
avidin–biotin immunoperoxidase method (ZYMED detection
Carlsbad, CA, USA). Paraffin-embedded 4 mm sections were
deparaffinized with xylene, rehydrated in descending series of
ethanol and boiled in 10 mM citrate buffer. Endogenous peroxidase
was applied in 10% hydrogen peroxide in PBS  10 min followed by
an avidin/biotin blocking reagent. Primary antibodies for mouse
anti-a-SMA (1:200; Lab Vision Co., Fremont, CA, USA) and rat
anti-MOMA-2 (1:100; Accurate Chemical & Scientific Co Westbury,
NY, USA) mouse anti-fibronectin (1:50; Lab Vision Co.), rabbit
anti-collagen IV (1:300; Santa Cruz Bio, Santa Cruz, CA, USA) or
PBS negative control were incubated overnight at 41C. The sections
were washed twice for 5 min in PBS, incubated  30 min with
secondary antibodies, washed in PBS, and incubated  30 min with
Vectastain ABC reagent. Bound antibodies were detected using
substrate-chromagen mixture for a brown color. The sections were
stained with hematoxylin, dehydrated, and evaluated by light
microscopy and cortical tubular interstitial area. Myofibroblasts
stained positive for a-SMA and tubulointerstitial zone stained
positive for fibronectin and collagen IV. Both were quantified by
scanning 15 non-overlapping randomly selected fields on each
section at  200 magnification (excluding areas with blood vessels)
by a blinded observer. Immunohistochemical signal percent was
measured by computerized image analysis (Image Pro-Plus, Media
Cybernetics, Silver Spring, MD, USA).
Immunofluorescence
Paraffin-embedded 4 mm sections were deparaffinized with xylene,
rehydrated in descending series of ethanol and boiled in 10 mM
citrate buffer. The sections were incubated with 10% goat serum in
3% BSA for 1 h at room temperature. Primary rabbit CD68 antibody
(1:50; Santa-Cruz BIO) was added. As negative controls, PBS was
substituted for a primary antibody. The sections were incubated at
41C overnight, washed with PBS and incubated with goat anti-rabbit
IgG-TRITC at 1:200 dilution for 1 h. The sections were mounted
with DAPI and observed under fluorescent microscope/TRITC for
red color. Macrophages were counted manually in 15 non-
overlapping randomly selected fields/section at  400 magnification
by a blinded observer.
Proximal tubular epithelial cell culture
A vial of 2 105 LLC-PK1 porcine proximal tubular epithelial cells
(PTE: CL-101, ATTC, Manassas, VA, USA) was thawed and grown in
growth media containing 1.5 g/l sodium bicarbonate, 3% fetal
bovine serum and antibiotics. At 80% confluence, the cells were
starved for 16–20 h, and treated with rmOPN (10 nM) or AngII
(107 M) for 0, 4, 8, 16 and 24 h or varying concentrations of
rmOPN (0–10 nM) or AngII (0–104 M) for 24 h. Protein from
whole cell lysate was used for protein isolation in western blot
analysis (nX4 different cell preparations).
Western blot analysis
TGF-b1, NADPH oxidase subunits NOX4, NOX2, and gp47
phox and
nitrotyrosine, PAI-1, CD68, MCP-1, and a-SMA protein (40–60mg
renal cortex) was measured by western blot analysis using standard
procedures.39 Antibodies against TGF-b1 (1:100), PAI-1 (1:1000),
NOX2 (1:500), and gp47phox (1:1000; BD Biosciences/Pharmingen,
San Diego, CA, USA), anti-a-SMA (1:400; Lab Vision Co., Fermont,
CA), anti-MCP-1 (1:500), anti-CD68 (1:200) and anti-NOX4 (1:
250) anti-fibronectin (1:100; Santa-Cruz BIO), and nitrotyrosine
(1:500; Millipore Temecula, CA, USA) were used. Membranes were
probed with primary antibody and corresponding secondary
antibodies, signals were scanned and quantified by Image J version
1.28 U and NIH Image 1.60 scan software or by laser densitometry
(Molecular Dynamics, Sunnyvale, CA, USA). Protein from PTE cells
as above or pretreated with either anti-OPN antibody (1:100;
Santa-Cruz BIO)  2 h were used for TGF-b1 or a-SMA expression.
Following enhanced chemiluminescence (ECL) detection of pro-
teins, the membranes were stripped and rehybridized with b-actin
antibody as a loading control. At least four independent cell
preparations were used.
Reverse transcription real-time polymerase chain reaction
(qRT-PCR)
OPN, MCP-1, TGF-b1, NOX4, and PAI-1 mRNA expression in
mouse renal cortex was measured by quantitative RT-PCR (n¼ 4–8
animals/group). Total RNA (30–45 mg) was isolated by the Trizol
method (Invitrogen Life Technologies, Carlsbad, CA, USA) and
DNase-treated. Total RNA (1000 ng) was reverse-transcribed using
TaqMan Reverse Transcription Reagent Kit (Applied Biosystems,
Foster City, CA, USA). The amount of contaminating DNA was
negligible in the absence of reverse transcriptase. PCR amplification
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of cDNA (100 ng) was performed with the ABI-PRISM 7700 system
(total volume: 25 ml), using a TaqMan PCR Core Reagent Kit. Each
sample was analyzed in triplicate and normalized to GAPDH mRNA
using Taqman Rodent GAPDH Control Reagent. The forward and
reverse primers (50 mm) and probes (50–100mm) labeled with
carboxyfluorescein dye used are listed in Table 2.
Statistical analysis
Data are expressed as mean±s.e.m. or mean±s.d., where indicated.
Data were tested for normality and when non-normal distribution
was present, differences between groups were detected by Kruskal–-
Wallis and Mann–Whitney U-tests; otherwise, analysis of variance
with Tukey post hoc tests was used. GraphPad Prizm 4 software (San
Diego, CA, USA) was used. Po0.05 was considered statistically
significant.
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